Nanogen to Close Array Business - Will Focus on Two High Growth Product Lines

Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that the Company plans to close commercial operations of the array business and reduce staff by approximately 20%. Today’s announcement follows the decision in September to investigate strategic alternatives for the array business.

Source: Nanogen